Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02421965 · ClinicalTrials.gov registry record · NA
Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness
A NA study of Schizophrenia and Major Depressive Disorder, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 174
- Enrollment target
- 1
- Study location
NCT02421965: Completed NA study of Schizophrenia and Major Depressive Disorder, sponsored by Dartmouth-Hitchcock Medical Center.
NCT02421965 is a NA study of Schizophrenia and Major Depressive Disorder that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 174 participants, below the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02421965, a NA study of Schizophrenia and Major Depressive Disorder, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 174 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is a three year research project whose aims are to evaluate the willingness of individuals with serious mental illness to initiate the two illness self-management interventions- WRAP or FOCUS, to examine and compare participant engagement, satisfaction, and outcomes (symptoms, recovery, quality of life) in the two interventions.
Primary Outcome
Patient willingness to enroll will be measured by proportion of individuals in each arm who commence the intervention after allocation. It is an important indicator of whether patients find the intervention appealing. Data will be obtained from electronic tracking records / FOCUS software.
Conditions Studied
Interventions
- BEHAVIORAL FOCUS (Smartphone Application)
- BEHAVIORAL WRAP (Wellness Recovery Action Planning)
Study Locations (1)
Illinois
- Thresholds Psychiatric Rehabilitation Centers - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-12 |
| Phase | NA |
What the finished NCT02421965 record still lists
NCT02421965 is an interventional study that assigns participants to a tested intervention. The registered 174 participants enrollment target is mid-sized for trials with a published cap, below the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (20% lower).
The record links to 4 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which FOCUS (Smartphone Application) is the first listed.
NCT02421965 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02421965 about?
NCT02421965 is a clinical study titled "Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness". The study is a three year research project whose aims are to evaluate the willingness of individuals with serious mental illness to initiate the two illness self-management interventions- WRAP or FOCUS, to examine and compare participant engagement, satisfaction, and outcomes (symptoms, recovery, qu...
What is the current status of trial NCT02421965?
This trial is currently completed. It is a NA study. The enrollment target is 174 participants. The study started on 2015-06. Estimated completion is 2017-12.
What conditions does trial NCT02421965 study?
This clinical trial studies the following conditions: Schizophrenia, Major Depressive Disorder, Bipolar Disorder, Schizoaffective Disorder.
What interventions are being tested in trial NCT02421965?
The interventions under investigation include: FOCUS (Smartphone Application) (BEHAVIORAL), WRAP (Wellness Recovery Action Planning) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02421965?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02421965 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02421965's enrollment target sits among peer trials
174 95th of 315 higher than 221 of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01000259 · 174 participants
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
- NCT04729114 · 174 participants · Phase 1
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- NCT04884035 · 174 participants · Phase 1
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
- NCT05075980 · 174 participants · Phase 2
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia